Calculated Individual Doses Using Specific Activity, Volume Administered, and Assumption of 7 × 105 Antigen/Cell
200-μm sphere | 300-μm sphere | |||
Single-cell dose (Gy) | 10-Gy* isodepth (μm) | Volume (%) > 10 Gy* | 10-Gy* isodepth (μm) | Volume (%) > 10 Gy* |
4.5 | 88 | 99.8 | 72 | 86 |
7.0 | 88 | 99.8 | 73 | 86 |
5.5 | 85 | 99.7 | 72 | 86 |
9.9 | 82 | 99.4 | 72 | 86 |
6.0 | 100 | 100.0 | 85 | 92 |
6.9 | 100 | 100.0 | 85 | 92 |
9.2 | 100 | 100.0 | 98 | 96 |
6.0 | 100 | 100.0 | 95 | 95 |
4.7 | 100 | 100.0 | 88 | 93 |
24.6 | 100 | 100.0 | 101 | 97 |
45.1 | 100 | 100.0 | 97 | 96 |
52.2 | 100 | 100.0 | 97 | 96 |
↵* Dose level that is considered sufficient for small-tumor eradication, presuming RBE of 5.